Clinical Associate Professor Research Articles

Stanford Initiative Engages Media About Mental Health, Suicide

Stanford Initiative Engages Media About Mental Health, Suicide

‘Accurate Empathy’: Psychotherapy’s Scalpel

‘Accurate Empathy’: Psychotherapy’s Scalpel

Psychiatrists Create Initiative to Educate Media About Suicide Contagion

Psychiatrists Create Initiative to Educate Media About Suicide Contagion

Archives, Recordkeeping, and Social Justice

Archives, Recordkeeping, and Social Justice

A2As or stimulants: which is better for treatment of ADHD in young children?

The use of α2-adrenergic agonists (A2As), like guanfacine and clonidine, in preschool-aged children with ADHD has been on the rise, even though little data support safety and effectiveness for these medications in this patient population. A May 2021 study conducted by Harstad and colleagues and published in JAMA compared the use of A2As with stimulants in childhood ADHD. Similar to other studies, the research team found that both A2As and stimulants were associated with improvement in ADHD symptoms for most children between approximately 4 and 6 years in whom they were initiated, with clinical improvement in 66% and 78% of young children, respectively. The study highlights the potential role that A2As could play in treating young children with ADHD, said Elizabeth Harstad, MD, MPH, a physician at Boston Children's Hospital and an assistant professor of pediatrics at Harvard Medical School. According to the American Academy of Pediatrics (AAP) and the Society for Developmental and Behavioral Pediatrics (SDBP), firstline therapy for ADHD is behavioral intervention, followed by stimulant treatment with methylphenidate (Ritalin) at the lowest effective dose if behavioral interventions are not sufficient. In general, AAP recommends behavioral therapy first then medication treatment, if necessary. Amphetamine salts (Adderall) are FDA-approved for children as young as 3 years because they were grandfathered in, not because there is stronger evidence for their use compared with methylphenidate, said Michael Ellis, DO, a child and adolescent psychologist and clinical associate professor at Mercer College of Medicine in Georgia. He said methylphenidate has more efficacy and safety data to promote its use, even though it is approved for individuals 6 years and older. “In general, I find less irritability with methylphenidate and prefer the use of that medication first, especially for those with ADHD and autism spectrum disorder,” Ellis said. The NIH's Preschool ADHD Treatment study, a randomized, placebo-controlled study, found that children between the ages of 3 and 5.5 years who were treated with methylphenidate had a significant reduction in ADHD symptoms, but often experienced adverse effects like irritability and depressive symptoms, like crying and sadness. The retrospective, medical records study in JAMA examined 497 preschool-age children younger than 6 years with ADHD. They came from seven academic developmental behavioral pediatric programs located in diverse geographical locations across the United States. “We found that developmental behavioral pediatricians use A2As when initiating medication treatment and use stimulant medication about two-thirds of the time,” said Harstad. “Children who were younger, or had a coexisting autism or sleep disorder, were more likely to be initiated on A2As.” Since stimulants are associated with more adverse effects than A2As—like moodiness/irritability (50% vs. 29%, respectively), appetite suppression (38% vs. 7%, respectively), and sleep difficulties (21% vs. 11%, respectively)—some providers prefer to prescribe A2As for their patients. “But these are not as effective for focus [compared with stimulants], and there can be a good deal of somnolence or hypotension,” said Ellis. Daytime sleepiness was the only adverse effect that was more common when young children with ADHD took A2As versus stimulants (38% vs. 3%, respectively), according to the study. A limitation of the study is its retrospective nature, which resulted in the collection of non-randomized and non-controlled data regarding the level of improvement over time, severity of baseline ADHD symptoms, and severity of adverse effects, said Harstad. “Medication may have been influenced by confounding factors [such as coexisting conditions]. Therefore, it is clinically imperative to conduct a prospective clinical study to assess effectiveness,” said Harstad. Preschool-aged children are being diagnosed with ADHD at higher rates than ever before. According to a 2018 article published in the Journal of Clinical Child & Adolescent Psychology, preschool ADHD rates have risen from 1.0% in 2007 to 2.4% in 2016. Since delay in early detection can lead to expulsion from preschool, future underachievement in school, and undue family stress, it is important for parents to have their child evaluated early on. “Preschoolers especially with severe ADHD likely need treatment right away,” said Ellis. While there are benefits and risks to treatments with both A2As and stimulants, options should be assessed with a patient-centered approach to optimize individual needs. Future randomized, controlled studies are also needed to assess efficacy and safety with both medication classes to determine more conclusive results.

Neurologic drugs for sleep disorders.

Mary Barna Bridgeman is a clinical associate professor at Rutgers University Ernest Mario School of Pharmacy in Piscataway, N.J. Kavitha S. Dalal is a critical care pharmacist at Virtua in Marlton, N.J. Unless otherwise specified, the information in the preceding summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breastfeeding. Also consult a pharmacist, the package insert, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions.

US Immigration Policies Pose Threat to Health Security During COVID-19 Pandemic.

Health SecurityVol. 19, No. S1 CommentaryCreative Commons licenseUS Immigration Policies Pose Threat to Health Security During COVID-19 PandemicHeather M. Ross, Stephanie Desiderio, Tomi St. Mars, and Paulette RangelHeather M. RossAddress correspondence to: Heather M. Ross, PhD, DNP, P.O. Box 875603, Tempe, AZ 85287-5603 E-mail Address: heather.m.ross@asu.eduHeather M. Ross, PhD, DNP, is a Clinical Associate Professor, School for the Future of Innovation in Society and Edson College of Nursing and Health Innovation, Arizona State University, Tempe, AZ. Stephanie Desiderio, RN, CHPN, was President, Greater Phoenix Area Chapter, Black Nurses Association; Tomi St. Mars, MSN, RN, CEN, FAEN, is Injury Prevention RN Coordinator, Trauma Services, Valleywise Health; and Paulette Rangel, RN, CCRN, is President, Phoenix Chapter, National Association of Hispanic Nurses; all in Phoenix, AZ.Search for more papers by this author, Stephanie DesiderioHeather M. Ross, PhD, DNP, is a Clinical Associate Professor, School for the Future of Innovation in Society and Edson College of Nursing and Health Innovation, Arizona State University, Tempe, AZ. Stephanie Desiderio, RN, CHPN, was President, Greater Phoenix Area Chapter, Black Nurses Association; Tomi St. Mars, MSN, RN, CEN, FAEN, is Injury Prevention RN Coordinator, Trauma Services, Valleywise Health; and Paulette Rangel, RN, CCRN, is President, Phoenix Chapter, National Association of Hispanic Nurses; all in Phoenix, AZ.Search for more papers by this author, Tomi St. MarsHeather M. Ross, PhD, DNP, is a Clinical Associate Professor, School for the Future of Innovation in Society and Edson College of Nursing and Health Innovation, Arizona State University, Tempe, AZ. Stephanie Desiderio, RN, CHPN, was President, Greater Phoenix Area Chapter, Black Nurses Association; Tomi St. Mars, MSN, RN, CEN, FAEN, is Injury Prevention RN Coordinator, Trauma Services, Valleywise Health; and Paulette Rangel, RN, CCRN, is President, Phoenix Chapter, National Association of Hispanic Nurses; all in Phoenix, AZ.Search for more papers by this author, and Paulette RangelHeather M. Ross, PhD, DNP, is a Clinical Associate Professor, School for the Future of Innovation in Society and Edson College of Nursing and Health Innovation, Arizona State University, Tempe, AZ. Stephanie Desiderio, RN, CHPN, was President, Greater Phoenix Area Chapter, Black Nurses Association; Tomi St. Mars, MSN, RN, CEN, FAEN, is Injury Prevention RN Coordinator, Trauma Services, Valleywise Health; and Paulette Rangel, RN, CCRN, is President, Phoenix Chapter, National Association of Hispanic Nurses; all in Phoenix, AZ.Search for more papers by this authorPublished Online:17 Jun 2021https://doi.org/10.1089/hs.2021.0039AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byUS public charge policy and Latinx immigrants’ thoughts about health and healthcare utilization15 February 2022 | Ethnicity & Health, Vol. 28, No. 1First, do no harm: why anti-immigrant policies in the United States are a public health concern22 September 2022 | Journal of Public Health Policy, Vol. 43, No. 3Changing the Narrative: Structural Barriers and Racial and Ethnic Inequities in COVID-19 Vaccination20 September 2021 | International Journal of Environmental Research and Public Health, Vol. 18, No. 18Why Social Distance Demands Social Justice: Systemic Racism, COVID-19, and Health Security in the United States Sanjana J. Ravi, Kelsey Lane Warmbrod, Allison Barlow, Javier Cepeda, Oluwaseun O. Falade-Nwulia, Emily E. Haroz, and Tanjala S. Purnell17 June 2021 | Health Security, Vol. 19, No. S1 Volume 19Issue S1Jun 2021 Information© Heather M. Ross et al., 2021; Published by Mary Ann Liebert, Inc.To cite this article:Heather M. Ross, Stephanie Desiderio, Tomi St. Mars, and Paulette Rangel.US Immigration Policies Pose Threat to Health Security During COVID-19 Pandemic.Health Security.Jun 2021.S-83-S-88.http://doi.org/10.1089/hs.2021.0039Published in Volume: 19 Issue S1: June 17, 2021Online Ahead of Print:June 4, 2021KeywordsCOVID-19ImmigrationPrivacyNational strategy/policyPublic health preparedness/responseSurveillanceOpen accessThis Open Access article is distributed under the terms of the Creative Commons License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.PDF download

Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau.

This interview was conducted by Atiya Henry, Commissioning Editor of Future Microbiology.Joseph M Blondeau, MSc, PhD, RSM(CCM), SM(AAM), SM(ASCP), FCCP is a Clinical Microbiologist and Head of Clinical Microbiology at Royal University Hospital (Saskatoon Health Region) and the University of Saskatchewan in Saskatoon, Canada. He is also the Provincial Clinical Lead for Microbiology in Saskatchewan, Canada. He holds a Masters of Sciences in Microbiology from Dalhousie University (1985) and a Doctor of Philosophy in Medical Microbiology from the University of Manitoba (1989). Following completion of his PhD, he completed a 1 and a half year post-doctoral training in an infectious diseases research laboratory at Dalhousie University and following which he completed a 2 year post-doctoral residency training program in Clinical Microbiology, also at Dalhousie University. He holds appointments as a Clinical Associate Professor of Pathology, Adjunct Professor of Microbiology and Immunology and Clinical Associate Professor of Ophthalmology. He teaches to undergraduate and graduate students in the areas of microbiology, infectious diseases, antimicrobial agents and pharmacology. Dr Blondeau’s main research interests are in the area of antimicrobial agents and antimicrobial resistance, clinical microbiology and clinical outcomes associated with antimicrobial therapy in both human and veterinary medicine.

Sarah A. Shaffer, DO, MME

Sarah A. Shaffer, DO, MME. University of Iowa Hospitals and Clinics. Clinical Associate Professor of Obstetrics and Gynecology-General Obstetrics and Gynecology Department of Obstetrics and Gynecology Clerkship Director - Obstetrics & Gynecology. University of Iowa Carver College of Medicine, Iowa City, Iowa

Finding the Yes Through a Thousand Points of No:: Quality Improvement in an Academic Medical Center

Quality improvement (QI) initiatives are integral to improving health care delivery in academic medical centers (AMCs), and evidence-based QI is the gold standard for the provision of safe and compassionate health care. Despite this, there is a lag in translating evidence into practice. This article addresses the reasons why QI is challenging to implement in AMCs and provides strategies to overcome the barriers. QI is possible, and it is essential to focus the provider's energies on implementing positive change in AMCs. Quality improvement (QI) initiatives are integral to improving health care delivery in academic medical centers (AMCs), and evidence-based QI is the gold standard for the provision of safe and compassionate health care. Despite this, there is a lag in translating evidence into practice. This article addresses the reasons why QI is challenging to implement in AMCs and provides strategies to overcome the barriers. QI is possible, and it is essential to focus the provider's energies on implementing positive change in AMCs. Lesley Coots, DNP, FNP-BC, FNP-C, CCRN, is a Nurse Practitioner at the Division of Plastic & Reconstructive Surgery, VCU Health, in Richmond, Virginia. She can be reached at [email protected] . Jeanette Amery, DNP, AGACNP-BC, is a Nurse Practitioner at the Division of Transplant Surgery, VCU Health. Christine Schaeffer, DNP, ACCNS-AG, CEN, TCRN, is a Nurse Clinician at the Adult Emergency Department and Clinical Decision Unit, VCU Health, Pamela Parsons, PhD, GNP-BC, FNAP, is a Clinical Associate Professor, and Associate Dean for Practice and Community Engagement, and Judith B. Collins and Joseph M. Teefey Distinguished Professor at Virginia Commonwealth University School of Nursing in Richmond, and Shelly Smith, DNP, ANP-BC, is a Clinical Associate Professor and Director of the DNP Program at the Virginia Commonwealth University School of Nursing in Richmond.

Oncology drugs

Mary Barna Bridgeman is a clinical associate professor at Rutgers University Ernest Mario School of Pharmacy in Piscataway, N.J., and Kavitha S. Dalal is a critical care pharmacist at Virtua in Marlton, N.J. Unless otherwise specified, the information in the preceding summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breastfeeding. Also consult a pharmacist, the package insert, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions.

An Interview with Jennifer Jordan and Amy Broemmel- Mastering the Art of Feedback for Pre-Service Teachers

Feedback is one of the most critical, crucial aspects of instruction and pedagogy, yet is often overlooked. There are many different types and forms of feedback and many different scenarios in which it can be provided. In this interview, two clinical teachers provide an overview of the realm of feedback, discuss ways in which it can be provided and review its use in the domain of pre-service teachers and teacher training.Amy Broemmel started her career as a 2nd grade teacher in a small town in northern Illinois before making a much earlier than expected transition to higher education. After teaching at Eastern Illinois University and the University of Wisconsin-LaCrosse, she was hired at the University of Tennessee where she is currently an Associate Professor of Elementary and Literacy Education. Her research focuses primarily on teacher development, but she also collaborates with a science education colleague to use picture books to build science content knowledge with elementary students. Her work has appeared in the American Educational Research Journal, The Reading Teacher, and Action in Teacher Education. She has also co-authored a book, Learning to be Teacher Leaders: A Framework for Assessment, Planning, and Instruction with Dr. Jennifer Jordan. Jennifer Jordan is a Clinical Associate Professor of elementary education and literacy at the University of Tennessee. She received her BA in sociology with a minor in elementary education from the University of Tennessee, Knoxville in 1998 and earned her MS in elementary education in 1999. After graduation she taught for 9 years in the Hamilton County and Knox County school systems teaching first and fourth grades. Her research focuses on the professional development of pre-service elementary teachers and in-service literacy teachers. Currently, she supervises elementary education teaching interns and teaches reading courses.

Gratitude and Acknowledgment

Some things are so obvious that it is easy to overlook their importance. While I use every opportunity to express my appreciation to the wonderful cadre of Journal of Women's Health Physical Therapy (JWHPT) reviewers, I haven't used this platform to acknowledge the tremendous work of our exceptional editors. Clearly, it is long overdue that I thank the work of Senior Editor, Mary Dockter; Associate Editors, Karen Abraham, Patty Nelson, Becca Reisch, and Tracy Spitznagle; Digital Media Editor, Rita Gillan; and Book Editor, Rebecca Stephenson. It's almost a cliché to say that 2020 was a difficult year. We all faced personal and professional challenges that previously were unimaginable. I am very fortunate to have this tight team that does its job extremely well despite obstacles. You may be familiar with some of the more typical work of journal editors for which I am very grateful. The Senior and Associate Editors play a huge role in the review process, assessing manuscripts and synthesizing reviewers' comments. This demanding work has many inherent rewards, but it can be time consuming as well as intellectually and emotionally draining. This work is more than scholarship; it is professional service. Because we value reading professionally enhancing material and providing sound recommendations to our patients and clients, the works of Rebecca and her book review team are important JWHPT contributions. Anyone who knows me understands that my social media literacy can be measured in the thimblefuls. Rita has patiently helped me understand some of the basics. With the help of Lindsay Durand and Ellen Meisner, Rita leads the digital media committee. You may have seen, liked, or shared information about JWHPT publications through our social platforms thanks to this committee. It makes me proud to say that this group is dedicated to making research a vital component of your professional life. With this motivation, we have accomplished so much more than what could reasonably be expected of an editorial team. I have chosen to highlight a few of these JWHPT activities. Video abstracts submitted with journal articles are an ongoing part of our effort to assist clinicians in translating research into clinical practice. At just a click away, these 3-minute videos provide a quick snapshot of the research conducted, enabling you to stay up to date, get insight into the authors' thinking, and inspire future research. You can find our video abstracts on our Web page by clicking the videos tab seen here: https://journals.lww.com/jwhpt/pages/videogallery.aspx. This year we were also able to realize our goal of creating a special topic issue. This time next year we will be bringing you a full issue on the important topic of postpartum health, titled, “The Fourth Trimester: Optimizing Health.” I am honored that Dr Sinéad Dufour, Associate Clinical Professor in the Faculty of Health Science at McMaster University and the Director of Pelvic Health and the World of my Baby (WOMB), has agreed to be the guest editor for this issue. I encourage authors working in any areas pertinent to postpartum health such as return to fitness (running, high-intensity exercise), diastasis rectus abdominis, breastfeeding, mental health, and sexual activity to submit an article for this important issue. In addition to maintaining the social media channels, Rita has worked with Lauren Trosch, Academy of Pelvic Health Multimedia Education Manager, in developing a virtual Journal Club as a collaboration between the JWHPT and the Academy of Pelvic Health Physical Therapy. These popular, free, hour-long webinars occur monthly, engaging professionals from across the globe and culminate in lively question-and-answer discussions. Our Editorial Advisory Board has changed. We thanked Jill Boissonnault, PT, PhD, WCS, for her contributions, particularly as she stepped away from the board. We welcomed 2 new members, Linda McLean, BScPT, PhD, MScE, and Susan C. Clinton, PT, DScPT, OCS, WCS, COMT, FAAOMPT. Linda is a full professor in the School of Rehabilitation Sciences at the University of Ottawa, heading an extensive research program on the study of biomechanical and neurophysiological mechanisms responsible for urinary incontinence, pelvic pain, and functional deficits associated with pregnancy and delivery. Susan, who is well known to the membership of the Academy of Pelvic Health for her years of service, is also the co-owner of Embody Physiotherapy and Wellness in Sewickley, Pennsylvania, and the cofounder and board member for the Global Women's Health Initiative. Susan is heading up a committee that will add a feature to our Web site called “Collections,” which will be a curated listing of the most important articles on selected topics. What a privilege it is to lead such a dedicated and hardworking team. I hope that this bit of recognition, which has been so obvious to me to be overlooked, will now be apparent to you. Many thanks to my great team for all they do! Cynthia M. Chiarello, PT, PhD Editor-in-Chief

Neurologic drugs.

Mary Barna Bridgeman is a clinical associate professor at Rutgers University Ernest Mario School of Pharmacy in Piscataway, N.J. Kavitha S. Dalal is a critical care pharmacist at Virtua in Marlton, N.J. Unless otherwise specified, the information in the preceding summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breastfeeding. Also consult a pharmacist, the package insert, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions.

Editorial introductions.

Editorial introductions.

Pandemic Halts School-to-Prison Pipeline, But Expected to Restart

Pandemic Halts School-to-Prison Pipeline, But Expected to Restart

Comparison of in-person and remote pediatric dentistry lectures before and during the COVID-19 pandemic.

Journal of Dental EducationVolume 85, Issue S3 p. 1917-1919 ADVANCING THROUGH INNOVATION Comparison of in-person and remote pediatric dentistry lectures before and during the COVID-19 pandemic Travis Nelson DDS, MSD, MPH, Corresponding Author Travis Nelson DDS, MSD, MPH tmnelson@uw.edu University of Washington, Seattle, USA Correspondence Travis Nelson, DDS, MSD, MPH, Clinical Associate Professor, University of Washington, Seattle, United States. Email: tmnelson@uw.eduSearch for more papers by this authorGrace Nelson RDH, Grace Nelson RDH University of Washington, Seattle, USASearch for more papers by this authorMarilynn Rothen RDH, MS, Marilynn Rothen RDH, MS University of Washington, Seattle, USASearch for more papers by this authorAmy Kim DDS, Amy Kim DDS University of Washington, Seattle, USA New York University Langone Health, Dental Medicine, New York, USASearch for more papers by this author Travis Nelson DDS, MSD, MPH, Corresponding Author Travis Nelson DDS, MSD, MPH tmnelson@uw.edu University of Washington, Seattle, USA Correspondence Travis Nelson, DDS, MSD, MPH, Clinical Associate Professor, University of Washington, Seattle, United States. Email: tmnelson@uw.eduSearch for more papers by this authorGrace Nelson RDH, Grace Nelson RDH University of Washington, Seattle, USASearch for more papers by this authorMarilynn Rothen RDH, MS, Marilynn Rothen RDH, MS University of Washington, Seattle, USASearch for more papers by this authorAmy Kim DDS, Amy Kim DDS University of Washington, Seattle, USA New York University Langone Health, Dental Medicine, New York, USASearch for more papers by this author First published: 15 January 2021 https://doi.org/10.1002/jdd.12532Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume85, IssueS3Supplement: Advancing Through InnovationDecember 2021Pages 1917-1919 This article also appears in:Advancing Through Innovation in a Challenging Time RelatedInformation

Editorial introductions

Editorial introductions

Revamping the Cytological Quantitation of Lipid Laden Macrophages in Bronchoalveolar Lavage

F Zahra Aly*, MD, PhD Author Affiliations Clinical Associate Professor, Department of Pathology, Immunology & Laboratory Medicine, University of Florida College of Medicine, Gainesville FL32610-0275 Received: October 08, 2020| Published: October 15, 2020 Corresponding author: F Zahra Aly, Clinical Associate Professor, Department of Pathology, Immunology & Laboratory Medicine, University of Florida College of Medicine, Gainesville FL32610-0275 DOI: 10.26717/BJSTR.2020.31.005063

College Students Struggle Amid Pandemic’s Uncertainty

College Students Struggle Amid Pandemic’s Uncertainty